Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients

计划入组 300 人 · 首次发布于 2023 年 10 月 19 日

Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

计划入组 16 人 · 首次发布于 2020 年 9 月 2 日

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

首次发布于 2020 年 6 月 26 日

LAB4

CDX/CD3

CDX-303

Tavotek Lab Inc

United States

Inventage Lab, Inc.

South Korea

REGEN LAB SA

Switzerland

Agilent Launches Biopharma CDx Services Lab to Advance Precision Medicine

BioPharma Services Expands into Late-Stage Trials with AI Integration

INCOG BioPharma Services Announces Major Facility and Capacity Expansion for 2025